NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

Q: What does CUSIP 44975P103 represent in this 13F holders report?

CUSIP 44975P103 is the security identifier for NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) used to aggregate holder disclosures.

Q: How many institutions held NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in Q1 2021?

78 institutional investors reported NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 44975P103

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding: 265,214,861
Total 13F shares: 23,316,491
Share change: +10,116,771
Total reported value: $1,130,077,433
Price per share: $48.47
Number of holders: 78
Value change: +$490,958,954
Number of buys: 54
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 44975P103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Cederberg Capital Ltd	13F	Company	0.67%	1,778,770	$83,869,000	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	0.6%	1,591,000	$75,016,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.56%	1,496,540	$70,562,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.53%	1,404,300	$66,213,000	—	31 Dec 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.32%	856,712	$40,394,000	—	31 Dec 2020	13F
WFM ASIA (BVI) Ltd	13F	Company	0.28%	752,937	$35,501,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.27%	725,000	$34,184,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.24%	633,388	$29,864,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.23%	606,070	$28,576,000	—	31 Dec 2020	13F
Octagon Capital Advisors LP	13F	Company	0.17%	454,550	$21,432,000	—	31 Dec 2020	13F
Bellevue Group AG	13F	Company	0.08%	203,212	$9,581,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.07%	189,236	$8,923,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.07%	181,820	$8,573,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.06%	151,520	$7,144,000	—	31 Dec 2020	13F
CVI Holdings, LLC	13F	Company	0.06%	151,520	$7,144,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.06%	150,885	$7,114,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.06%	150,218	$7,083,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.06%	150,000	$7,073,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.06%	146,955	$6,929,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.05%	140,400	$6,620,000	—	31 Dec 2020	13F
INDUS CAPITAL PARTNERS, LLC	13F	Company	0.05%	132,536	$6,249,000	—	31 Dec 2020	13F
Handelsbanken Fonder AB	13F	Company	0.04%	105,000	$4,951,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	102,609	$4,838,000	—	31 Dec 2020	13F
Perseverance Asset Management International	13F	Company	0.03%	89,000	$4,197,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	76,991	$3,630,000	—	31 Dec 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.03%	69,570	$3,280,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.02%	52,872	$2,493,000	—	31 Dec 2020	13F
Vident Investment Advisory, LLC	13F	Company	0.02%	52,550	$2,478,000	—	31 Dec 2020	13F
Maven Securities LTD	13F	Company	0.02%	44,411	$2,094,000	—	31 Dec 2020	13F
Allianz Asset Management GmbH	13F	Company	0.01%	38,895	$1,834,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.01%	34,966	$1,649,000	—	31 Dec 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.01%	34,289	$1,454,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	30,499	$1,438,000	—	31 Dec 2020	13F
Long Corridor Asset Management Ltd	13F	Company	0.01%	30,000	$1,415,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.01%	30,000	$1,415,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.01%	23,618	$1,114,000	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0.01%	20,989	$990,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.01%	17,740	$836,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	16,007	$755,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.01%	15,292	$721,000	—	31 Dec 2020	13F
Sio Capital Management, LLC	13F	Company	0.01%	15,000	$707,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.01%	13,597	$641,000	—	31 Dec 2020	13F
HSBC HOLDINGS PLC	13F	Company	0.01%	13,620	$640,000	—	31 Dec 2020	13F
NEW SILK ROAD INVESTMENT PTE LTD	13F	Company	0%	12,000	$566,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0%	10,492	$494,000	—	31 Dec 2020	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0%	9,545	$450,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0%	8,634	$407,000	—	31 Dec 2020	13F
Jump Financial, LLC	13F	Company	0%	7,856	$370,000	—	31 Dec 2020	13F
VIRTUS ADVISERS, LLC	13F	Company	0%	7,725	$364,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0%	7,564	$356,000	—	31 Dec 2020	13F

Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2021

As of 31 Mar 2021, NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,316,491 shares. The largest 10 holders included HILLHOUSE CAPITAL ADVISORS, LTD., Cederberg Capital Ltd, Ward Ferry Management (BVI) Ltd, Avidity Partners Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Artisan Partners Limited Partnership, Artal Group S.A., MANUFACTURERS LIFE INSURANCE COMPANY, THE, PRICE T ROWE ASSOCIATES INC /MD/, and Octagon Capital Advisors LP. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.